Vertex Pharmaceuticals
VRTX
#175
Rank
A$175.81 B
Marketcap
A$685.73
Share price
-0.41%
Change (1 day)
-3.83%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$11.35 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's total liabilities are A$11.35 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vertex Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$9.84 B30.25%
2023-12-31A$7.55 B21.37%
2022-12-31A$6.22 B35.49%
2021-12-31A$4.59 B15.32%
2020-12-31A$3.98 B24.97%
2019-12-31A$3.18 B24.1%
2018-12-31A$2.57 B33.44%
2017-12-31A$1.92 B-10.92%
2016-12-31A$2.16 B12.12%
2015-12-31A$1.92 B27.44%
2014-12-31A$1.51 B40.22%
2013-12-31A$1.07 B-28.27%
2012-12-31A$1.50 B20.91%
2011-12-31A$1.24 B3.47%
2010-12-31A$1.20 B25.73%
2009-12-31A$0.95 B-9.01%
2008-12-31A$1.05 B178.33%
2007-12-31A$0.37 B-28.37%
2006-12-31A$0.52 B24.52%
2005-12-31A$0.42 B-35.75%
2004-12-31A$0.65 B-7.84%
2003-12-31A$0.71 B-7.83%
2002-12-31A$0.77 B-11.96%
2001-12-31A$0.88 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
A$55.81 B 391.51%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$205.49 B 1,709.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$116.88 B 929.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$117.86 B 937.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$170.93 B 1,405.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
A$0.33 B-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA